An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ICON (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organization, will release its financial results for Q4 2022 on February 22, 2023, after market close. A conference call to discuss the results will be held on February 23, 2023, at 8:00 am ET. The company, headquartered in Dublin, Ireland, employed approximately 41,150 employees across 113 locations in 53 countries as of September 30, 2022. Investors are advised that this release contains forward-looking statements subject to risks and uncertainties, and should not rely solely on them for investment decisions.
Positive
None.
Negative
None.
DUBLIN--(BUSINESS WIRE)--
ICONplc(NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the fourth quarter 2022 after the market closes on Wednesday, February 22, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, February 23, 2023 at 8:00am ET.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “Events”. A webcast replay of the conference call will be available approximately one hour following the conclusion of the call.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as at September 30, 2022. For further information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.
Kate Haven Vice President Investor Relations
+1888 381 7923
Source: ICON plc
FAQ
When will ICON release its fourth quarter 2022 financial results?
ICON will release its fourth quarter 2022 financial results on February 22, 2023, after market close.
What time is the conference call to discuss ICON's financial results?
The conference call to discuss ICON's financial results will be held on February 23, 2023, at 8:00 am ET.
Where can I find the webcast for ICON's financial results?
The webcast for ICON's financial results can be found on the Investor section of their website under 'Events.'
How many employees did ICON have as of September 30, 2022?
As of September 30, 2022, ICON had approximately 41,150 employees.
What is the significance of forward-looking statements in ICON's press release?
Forward-looking statements in ICON's press release reflect management's expectations and are subject to numerous risks and uncertainties that could cause actual results to differ.